MedPath

Etiology and Prognosis of sICH Based on Hemorrhage Location

Completed
Conditions
Spontaneous Intracerebral Hemorrhage
Registration Number
NCT06498778
Lead Sponsor
Jinling Hospital, China
Brief Summary

The investigators retrospectively collected participants with spontaneous cerebral hemorrhage(sICH) from January 2015 to December 2019 for training and internal validation. Clinical and imaging data were collected. Modified Rankin Scale (mRS) scores were determined good outcome as "mRS = 0-2", poor outcome as "mRS = 3-6". The location features of sICH were extracted by symptom mapping. Noncontrast computed tomography images of patients and hematoma masks were registered with standard human brain templates to identify specific affected brain regions. Then a probability map of hemorrhage for different causes and prognosis is generated. PyRadiomics was used to extract the radiomic features, integrate radiomic and clinical features into multiple logistic regression models, and develop and validate optimal etiological and prognostic models. Further tests were performed in an independent cohort. The area under the working characteristic curve (AUC), sensibility, specificity were used to evaluate the reliability of the model.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
698
Inclusion Criteria
  • The confirmation of intracranial hemorrhage was achieved through NCCT.
Exclusion Criteria
  • They presented with secondary hemorrhage resulting from head trauma, hemorrhagic transformation of ischemic infarction, brain tumors, or exhibited abnormalities in blood coagulation, liver, kidney function, or were subject to drug-induced cerebral hemorrhage
  • Only postoperative CT images were available
  • Lost follow-up records
  • CT image artifacts

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Modified Rankin Scale (mRS) scoresfollow-ups at twelve months post sICH event

Good outcome as "mRS = 0-2", poor outcome as "mRS = 3-6"

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Jinling Hospital

🇨🇳

Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath